Safety and Cardiovascular Efficacy of Spironolactone in Dialysis-Dependent ESRD Trial
Status:
Completed
Trial end date:
2017-07-30
Target enrollment:
Participant gender:
Summary
The SPin-D Trial is a phase II randomized, double-blind, placebo-controlled, multi-center
study of spironolactone (SPL) for patients with hemodialysis-dependent end-stage renal
disease.
Phase:
Phase 2
Details
Lead Sponsor:
University of Pennsylvania
Collaborators:
Brigham and Women's Hospital George Washington University University of Washington Vanderbilt University